Immucor INC:1106670 [18-004952]

Ended Awarded Last action

Contract number
HHSN269201800023U
Awardee
Awarding agency
Obligated
$11,054

Award facts

Contract value 100% obligated
$11,053.97 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institutes of Health Clinical Center issued a delivery order to Immucor Inc. on January 18, 2026, with a ceiling value of $11,053.97 under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests.

Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of January 31, 2026. No set-aside was used.

Quick answers

Who was awarded contract HHSN269201800023U?

HHSN269201800023U was awarded to Immucor Inc. by NIH Clinical Center (National Institutes of Health) on January 18, 2018.

How much is contract HHSN269201800023U worth?

The government has obligated $11,054 on HHSN269201800023U.

Is contract HHSN269201800023U an order under another contract?

Yes. HHSN269201800023U is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract HHSN269201800023U competed?

The extent of competition for HHSN269201800023U was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award